Localizing Product Content for Pharma E-Commerce in the United States

Format: Guide Article | Audience: International Teams, Content Ops | Keywords: e-commerce localization healthcare US, global product content strategy, optimize Amazon.com listings pharma US

Introduction: The United States Isn't Just "Another North American Market"

When a CHC (Consumer Healthcare) brand decides to sell its products in the United States via e-commerce, the first instinct is often to take existing content — listings that perform on Amazon.de, Amazon.co.uk, or other international marketplaces — and translate them into English. After all, a magnesium supplement is a magnesium supplement regardless of the country. The ingredients are the same, the dosage is the same, and consumers are looking for the same thing: a reliable product that meets their health needs.

This logic is appealing. It is also dangerous.

The US online health market is a radically different environment from its international counterparts. Online sales of health products represent approximately 13% of total pharmacy sales in the United States — a figure that places the country well ahead of most European markets in terms of healthcare e-commerce penetration. This market is experiencing dynamic growth: platforms are multiplying (Amazon.com, CVS Pharmacy online, Walgreens, Amazon Pharmacy), and American consumers are increasingly purchasing health products online, particularly over-the-counter medications, dietary supplements, and medical devices.

However, this growing market is also one of the most regulated in the world. The FDA (Food and Drug Administration), FTC (Federal Trade Commission), and state health authorities each oversee different aspects of product content — from health claims to visual presentation to sales conditions. Only licensed pharmacies can legally sell prescription medications online. And the rules that govern content are not the same as those in Europe, Canada, or other international markets.